-
miR-4769-3p and Adipogenesis in Systemic Sclerosis
2026-09-02
Tang et al. identify miR-4769-3p as an inhibitor of subcutaneous adipose tissue recovery in systemic sclerosis and define a mechanistic USP18/VDAC2 axis connecting microRNA activity with adipogenesis. The study combines patient samples, a bleomycin-induced mouse model, and 3T3-L1 cell experiments to support a potential molecular target for studying adipose loss and skin fibrosis.
-
Apicidin Disrupts Oocyte Maturation and Histone Acetylation
2026-09-01
A 2026 study identifies a reproductive-toxicity mechanism for Apicidin by linking impaired oocyte meiotic maturation with spindle defects, actin disorganization, altered histone and tubulin acetylation, DNA damage, and early apoptosis. The work provides a framework for evaluating Apicidin exposure in germ-cell models while highlighting that HDAC-related molecular changes should not be interpreted as proof of direct target inhibition without biochemical validation.
-
Fucoidan: Gut–Liver Axis Research Workflows
2026-09-01
Fucoidan connects cancer-cell apoptosis assays with gut–liver barrier and inflammatory models, enabling researchers to separate direct tumor effects from host-mediated protection. This practical guide covers formulation, NETs-focused readouts, assay controls, and troubleshooting for more reproducible translational studies.
-
Belinostat (PXD101): HDAC-to-Splicing Insights
2026-08-31
Belinostat (PXD101) is a hydroxamate-type pan-HDAC inhibitor for studying chromatin acetylation, cell-cycle control, and cancer biology. This article connects its established bladder and prostate models with new assay insights from acetylation-dependent spliceosome research in hepatocellular carcinoma.
-
CerS6 Links Restraint Stress to Liver Mitochondrial Injury
2026-08-31
Liu et al. identify CerS6-derived mitochondrial C16:0 ceramide as a mechanistic link between glucocorticoid stress signaling and hepatocyte mitochondrial injury. Their combined rat, hepatocyte, lipidomic, pathway-inhibition, and gene-silencing experiments provide a framework for studying stress-related liver damage while highlighting the need to preserve phosphorylation states during sample handling.
-
Z-IETD-FMK for Caspase-8 Assays
2026-08-30
Z-IETD-FMK enables targeted interrogation of caspase-8 in activated T cells, death-receptor models, and cross-species cell-death studies. This workflow-focused guide shows how to manage DMSO stocks, separate pathway inhibition from cytotoxicity, and interpret caspase-8 results alongside NF-κB and GSDME-dependent pyroptosis readouts.
-
M344 Histone Deacetylase Inhibitor Workflows
2026-08-29
M344 is a cell-permeable histone deacetylase inhibitor for connecting chromatin remodeling with measurable changes in proliferation, differentiation, apoptosis, migration, and treatment response. This practical guide translates neuroblastoma findings into assay-ready workflows while addressing solubility, exposure, toxicity, and cross-domain applications.
-
SP2509: Lysine-Specific Demethylase 1 Antagonist
2026-08-28
SP2509 enables selective interrogation of LSD1–CoREST biology, connecting H3K4 methylation changes with apoptosis and differentiation phenotypes in acute myeloid leukemia models. This workflow guide covers compound preparation, chromatin and cellular readouts, combination-study design, and practical troubleshooting.
-
Early Pheromone Sensing and Neurodegeneration
2026-08-28
Peng et al. show that pheromone exposure during the L1 stage of C. elegans can remodel neural development and accelerate neurodegeneration in adulthood. Their work identifies a circuit linking ASK and ASI chemosensory neurons, AIA interneurons, insulin-like signaling, and neuronal autophagy, offering a mechanistic framework for how early environmental cues influence later proteostasis.
-
Trichostatin A: From Chromatin Control to Translation
2026-08-27
Trichostatin A (TSA) is more than a benchmark HDAC inhibitor: it is a reversible epigenetic perturbation tool for connecting histone acetylation with cell-state transitions, proliferation, and differentiation. This thought-leadership guide links TSA-enabled cancer research with chromatin studies of cardiomyocyte maturation, using the cited perinatal-transition study to frame a more rigorous translational workflow. It also outlines practical protocol parameters, evidence thresholds, competitive positioning, and the limitations that must be addressed before mechanistic observations are interpreted as therapeutic potential.
-
PP 2 (AG 1879): A Pathway-Resolved Assay Guide
2026-08-27
PP 2 (AG 1879) is a potent Src-family kinase probe for cancer research, immunology, and pathway analysis. This guide connects its Lck/Fyn pharmacology with the PA–Src–FAK–RhoA/ROCK cytoskeletal pathway and translates that biology into more informative assay decisions.
-
Tunicamycin Workflows for ER Stress Research
2026-08-26
Use Tunicamycin as a controlled N-glycosylation inhibitor to connect glycoprotein processing with ER stress, macrophage inflammation, and autophagy-related phenotypes. This workflow emphasizes dose-finding, orthogonal readouts, and careful interpretation across mammalian and plant systems.
-
Protein A/G Magnetic Co-IP/IP Kit: From Binding to Biology
2026-08-26
The Protein A/G Magnetic Co-IP/IP Kit connects selective Fc capture with rigorous protein-protein interaction analysis. Using the AP2-M Babesia study as a model, this article explains how to distinguish DNA occupancy, protein association, and functional evidence in complex immunoprecipitation workflows.
-
VE-822: ATR Inhibition Beyond Checkpoints
2026-08-25
VE-822 is a potent ATR inhibitor for dissecting replication-stress signaling, DNA damage response inhibition, and tumor sensitization. This article connects ATR perturbation with nuclear cGAS–TRIM41 control of LINE-1, offering a distinct framework for mechanistic assays and PDAC research.
-
Standardized Whole-Blood Immunometabolism Assay
2026-08-25
Zhao and colleagues introduce a standardized fresh whole-blood stimulation workflow that combines defined immune challenges with pharmacological metabolism modulation and cytokine measurement. The protocol provides a practical framework for comparing donor responses and studying how anabolic and catabolic pathways shape immune activation without relying exclusively on isolated-cell systems.